Full Text View
Tabular View
No Study Results Posted
Related Studies
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies
This study has been terminated.
Study NCT00040417   Information provided by Baylor College of Medicine
First Received: June 26, 2002   Last Updated: April 9, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sickle Cell Anemia
Hemoglobinopathy
Thalassemia
Additional conditions recognized in this trial
Anemia, Sickle Cell
Hemoglobinopathies
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Interventions listed in this trial
FLUDARABINE
CAMPATH-IH
Total Body Irradiation
FK506
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Baylor College of Medicine
Texas Children's Hospital
The Methodist Hospital System


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services